Invus Public Equities, L.P. 13D and 13G filings for Solid Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 6:50 pm Purchase | 2025-03-31 | 13G | Solid Biosciences Inc. SLDB | Invus Public Equities, L.P. | 7,415,905 9.600% | 3,666,864 (+97.81%) | Filing |
| 2025-02-12 4:30 pm Purchase | 2024-12-31 | 13G | Solid Biosciences Inc. SLDB | Invus Public Equities, L.P. | 3,749,041 9.400% | 1,000,000 (+36.38%) | Filing |
| 2024-11-12 4:58 pm Purchase | 2024-09-30 | 13G | Solid Biosciences Inc. SLDB | Invus Public Equities, L.P. | 2,749,041 7.100% | 240,898 (+9.60%) | Filing |
| 2024-08-02 6:37 pm Purchase | 2024-07-25 | 13G | Solid Biosciences Inc. SLDB | Invus Public Equities, L.P. | 2,508,143 6.500% | 2,508,143 (New Position) | Filing |